Related Experiment Video

Updated: Aug 19, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid

Chunhui Di1, Shaoxi Liao, David C Adamson

  • 1Brain Tumor Center, Department of Pathology, Duke University Medical Center, Research Drive, Durham, NC 27710, USA.

Cancer Research
|February 12, 2005
PubMed

Insights

The homeobox gene OTX2 is amplified in anaplastic medulloblastomas, driving tumor growth. Targeting OTX2 with all-trans retinoic acid may offer a new therapeutic strategy for these aggressive brain tumors.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Medulloblastoma is a common pediatric brain tumor.
  • Anaplastic medulloblastomas are a high-risk subtype with poor prognosis.
  • The molecular drivers of anaplastic medulloblastomas are not fully understood.

Purpose of the Study:

  • To investigate the role of the homeobox gene OTX2 in medulloblastoma pathogenesis.
  • To explore OTX2 as a potential therapeutic target in anaplastic medulloblastomas.

Main Methods:

  • Digital karyotyping of medulloblastoma cell lines.
  • Gene expression analysis of OTX2.
  • siRNA-mediated knockdown of OTX2.
  • In vitro cell growth assays.
  • Treatment with all-trans retinoic acid (ATRA).

Main Results:

  • OTX2 gene amplification (>10-fold) identified in 3/3 medulloblastoma cell lines.
  • High OTX2 transcript levels observed in 93% of anaplastic medulloblastomas.
  • OTX2 knockdown inhibited medulloblastoma cell proliferation.
  • ATRA repressed OTX2 expression and induced apoptosis in OTX2-expressing medulloblastoma cells.

Conclusions:

  • OTX2 is crucial for the development of anaplastic medulloblastomas.
  • OTX2 represents a potential therapeutic target.
  • Anaplastic medulloblastomas expressing OTX2 may respond to all-trans retinoic acid therapy.

More Related Videos

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...